Reducing the Incidence and Spread of Methicillin-Resistant Staphylococcus aureus (MRSA): A Toolkit for Addressing Hospital-Acquired MRSA
SmartMobile(TM)
Premiere Date: Tuesday, August 27, 2013This activity offers CE credit for:
- Physicians (CME)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, August 27, 2014
Note: Credit Is No Longer Available
 | Richard Snow, DO, MPH (Moderator) System Vice President Clinical Effectiveness OhioHealth Columbus , OH |
 | Ian M. Baird, MD, FACP Infectious Disease Specialist Remington-Davis Clinical Research Columbus, OH |
 | Jennifer Beard, MD, FACP Program Director Canton Medical Education Foundation Canton, OH |
 | Lita Jo Henman, MPH, CIC Infection Control Prevention Program Riversity Methodist Hospital Columbus, OH |
 | Shawn Kerger, DO, FAOASM Medical Director Peter E. Johnston, D.O. Simulation and Education Center Physician Education Specialists Department of Graduate Medical Education OhioHealth Columbus, OH |
 | Mysheika LaMaile-Williams, MD, MPH Assistant Health Commissioner Medical Director Columbus Public Health Columbus, OH |
 | Ari Robicsek, MD Clinical Associate Professor University of Chicago Pritzer School of Medicine Vice Preseident for Clinical and Quality Informatics NorthShore Unviersity HealthSystem Evanston, IL |
 | Marcus Topinka, MD Emergency Medicine Research Director Doctors Hospital Columbus, OH |
Methicillin-resistant Staphylococcus aureus (MRSA) is a key pathogen in many healthcare-associated infections, infections that occur in up to 10% of hospitalized patients and account for nearly 80,000 deaths annually in the United States. As the epidemiology of MRSA continues to evolve, the current challenge is to use the most appropriate and effective therapeutic and preventive strategies against this pathogen. However, studies show that compliance with such strategies could be vastly improved.
This online educational toolkit provides video footage from an educational roundtable of clinical experts who discuss strategies for prevention and control of MRSA infection in the hospital setting. The goal of this toolkit is to promote a “change model” that incorporates thought, culture, and practice by identifying evidence-based measures, assessing practice against those measures, and implementing interventions for performance improvement in addressing healthcare-associated infections caused by MRSA.
To promote a change model that incorporates thought, culture, and practice by identifying evidence-based measures, assessing practice against those measures, and implementing interventions for performance improvement in addressing healthcare-associated infections caused by MRSA.
At the end of this CE activity, participants should be able to:
- Describe how methicillin-resistant Staphylococcus aureus (MRSA) is transmitted in the hospital setting.
- Consistently use contact precautions when they are caring for hospitalized patients infected with MRSA.
- Increase the rate at which they treat complicated skin and soft tissue infections as if they are MRSA-infected until proven otherwise by culture results.
Supported by educational grants from Cubist Pharmaceuticals, Inc. and Pfizer Inc.
Physicians, nurse practitioners, physician assistants, and health care professionals who are involved in providing care for hospital inpatients with or at risk for acquiring MRSA infection.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST784 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Snow has no disclosures to report.
Dr. Baird has disclosed that he received research support from Pfizer Inc. and Wyeth Pharmaceuticals.
Dr. Beard has no disclosures to report.
Ms. Henman has no disclosures to report.
Dr. Kerger has no disclosures to report.
Dr. LaMaile-Williams has no disclosures to report.
Dr. Robicsek has disclosed that he has received research and grant support from Becton, Dickenson and Company. He has served as a speaker at symposia sponsored by Becton, Dickinson ad Company.
Dr. Topinka has no disclosures to report.
Jeffrey Helfand, DO, MS (Content/peer reviewer) has no disclosures to report.
Monique Johnson, MD, CCMEP (planning committee) has no disclosures to report.
Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.
Joy B. Leffler, MLA, NASW (planning committee) has no disclosures to report.
Nancy Davis, PhD (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, Cubist Pharmaceuticals, Inc., and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
SM-004-082713-90
